The phytoestrogen genistein promotes wound healing by multiple independent mechanisms

Molecular and Cellular Endocrinology

Volumn 321, Issue 2, 2010, Pages 184-193

  Emmerson, Elaine ^a   Campbell, Laura ^a   Ashcroft, Gillian S ^a   Hardman, Matthew J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Estrogen receptor; Genistein; Ovariectomy; SERMs; Wound healing

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GELATINASE B; GENISTEIN; INTERLEUKIN 6; JB 3; RECEPTOR BLOCKING AGENT; SOMATOMEDIN C RECEPTOR ANTAGONIST; TOCRIS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; PHYTOESTROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL MIGRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; EPITHELIZATION; FEMALE; HUMAN; IN VIVO STUDY; MACROPHAGE; MONOTHERAPY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN FUNCTION; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARIECTOMY; POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BASE SEQUENCE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GENISTEIN; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OVARIECTOMY; PHYTOESTROGENS; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; WOUND HEALING;

EID: 77951252806     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.026     Document Type: Article

References (63)

1. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., Bonds D., Brunner R., Brzyski R., Caan B., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712.
2. Ashcroft G.S., Dodsworth J., van Boxtel E., Tarnuzzer R.W., Horan M.A., Schultz G.S., Ferguson M.W. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat. Med. 1997, 3:1209-1215.
3. Ashcroft G.S., Greenwell-Wild T., Horan M.A., Wahl S.M., Ferguson M.W. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am. J. Pathol. 1999, 155:1137-1146.
4. Ashcroft G.S., Horan M.A., Ferguson M.W. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab. Invest. 1998, 78:47-58.
5. Ashcroft G.S., Horan M.A., Herrick S.E., Tarnuzzer R.W., Schultz G.S., Ferguson M.W. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res. 1997, 290:581-591.
6. Ashcroft G.S., Mills S.J. Androgen receptor-mediated inhibition of cutaneous wound healing. J. Clin. Invest. 2002, 110:615-624.
7. Ashcroft G.S., Mills S.J., Lei K., Gibbons L., Jeong M.J., Taniguchi M., Burow M., Horan M.A., Wahl S.M., Nakayama T. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J. Clin. Invest. 2003, 111:1309-1318.
8. Ashworth J.J., Smyth J.V., Pendleton N., Horan M., Payton A., Worthington J., Ollier W.E., Ashcroft G.S. The dinucleotide (CA) repeat polymorphism of estrogen receptor beta but not the dinucleotide (TA) repeat polymorphism of estrogen receptor alpha is associated with venous ulceration. J. Steroid Biochem. Mol. Biol. 2005, 97:266-270.
9. Ashworth J.J., Smyth J.V., Pendleton N., Horan M., Payton A., Worthington J., Ollier W.E., Ashcroft G.S. Polymorphisms spanning the 0N exon and promoter of the estrogen receptor-beta (ERbeta) gene ESR2 are associated with venous ulceration. Clin. Genet. 2008, 73:55-61.
10. Atteritano M., Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., Mazzaferro S., D'Anna R., Cannata M.L., Gaudio A., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 2007, 92:3068-3075.
11. Berard A., Kahn S.R., Abenhaim L. Is hormone replacement therapy protective for venous ulcer of the lower limbs?. Pharmacoepidemiol. Drug. Saf. 2001, 10:245-251.
12. Bian Z.M., Elner S.G., Yoshida A., Elner V.M. Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade. Exp. Eye Res. 2003, 76:573-583.
13. Borras C., Gambini J., Gomez-Cabrera M.C., Sastre J., Pallardo F.V., Mann G.E., Vina J. Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. FASEB J. 2006, 20:2136-2138.
14. Brand R.M., Jendrzejewski J.L. Topical treatment with (-)-epigallocatechin-3-gallate and genistein after a single UV exposure can reduce skin damage. J. Dermatol. Sci. 2008, 50:69-72.
15. Cassidy A., Albertazzi P., Lise Nielsen I., Hall W., Williamson G., Tetens I., Atkins S., Cross H., Manios Y., Wolk A., et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc. Nutr. Soc. 2006, 65:76-92.
16. Cederroth C.R., Nef S. Soy, phytoestrogens and metabolism: a review. Mol. Cell. Endocrinol. 2009, 304:30-42.
17. Chen W.F., Wong M.S. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J. Clin. Endocrinol. Metab. 2004, 89:2351-2359.
18. De Paula M.L., Rodrigues D.H., Teixeira H.C., Barsante M.M., Souza M.A., Ferreira A.P. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis. Int. Immunopharmacol. 2008, 8:1291-1297.
19. Diegelmann R.F., Cohen I.K., Kaplan A.M. The role of macrophages in wound repair: a review. Plast. Reconstr. Surg. 1981, 68:107-113.
20. Duan W.R., Patyna S., Kuhlmann M.A., Li S., Blomme E.A. A multitargeted receptor tyrosine kinase inhibitor. SU6668, does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice. J. Invest. Surg. 2006, 19:245-254.
21. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:1952-1957.
22. Emmerson E., Campbell L., Ashcroft G.S., Hardman M.J. Unique and synergistic roles for 17beta-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific. Endocrinology 2009, 150:2749-2757.
23. Fanti P., Monier-Faugere M.C., Geng Z., Schmidt J., Morris P.E., Cohen D., Malluche H.H. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos. Int. 1998, 8:274-281.
24. Gambrell R.D. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil. Steril. 1982, 37:457-474.
25. Gilliver S.C., Ashcroft G.S. Sex steroids and cutaneous wound healing: the contrasting influences of estrogens and androgens. Climacteric 2007, 10:276-288.
26. Gilliver S.C., Ruckshanthi J.P., Atkinson S.J., Ashcroft G.S. Androgens influence expression of matrix proteins and proteolytic factors during cutaneous wound healing. Lab. Invest. 2007, 87:871-881.
27. Govindan R., Behnken D., Read W., McLeod H. Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib. Ann. Oncol. 2003, 14:1330-1331.
28. Hager B., Bickenbach J.R., Fleckman P. Long-term culture of murine epidermal keratinocytes. J. Invest. Dermatol. 1999, 112:971-976.
29. Hardman M.J., Ashcroft G.S. Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly. Genome Biol. 2008, 9:R80.
30. Hardman M.J., Emmerson E., Campbell L., Ashcroft G.S. Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice. Endocrinology 2008, 149:551-557.
31. Hardman M.J., Waite A., Zeef L., Burow M., Nakayama T., Ashcroft G.S. Macrophage migration inhibitory factor: a central regulator of wound healing. Am. J. Pathol. 2005, 167:1561-1574.
32. Jefferson W., Newbold R., Padilla-Banks E., Pepling M. Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biol. Reprod. 2006, 74:161-168.
33. Josefsson E., Tarkowski A., Carlsten H. Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol. 1992, 142:67-78.
34. Kim H., Peterson T.G., Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am. J. Clin. Nutr. 1998, 68:1418S-1425S.
35. Kim N., Gross C., Curtis J., Stettin G., Wogen S., Choe N., Krumholz H.M. The impact of clinical trials on the use of hormone replacement therapy. A population-based study. J. Gen. Intern. Med. 2005, 20:1026-1031.
36. Klotz D.M., Hewitt S.C., Ciana P., Raviscioni M., Lindzey J.K., Foley J., Maggi A., DiAugustine R.P., Korach K.S. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J. Biol. Chem. 2002, 277:8531-8537.
37. Klotz D.M., Hewitt S.C., Korach K.S., Diaugustine R.P. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha. Endocrinology 2000, 141:3430-3439.
38. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
39. Li Z., Li J., Mo B., Hu C., Liu H., Qi H., Wang X., Xu J. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol. Toxicol. 2008, 24:401-409.
40. Liu D., Jiang H., Grange R.W. Genistein activates the 3′,5′-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 2005, 146:1312-1320.
41. Loots M.A., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J. Invest. Dermatol. 1998, 111:850-857.
42. Lu H., Shi J.X., Zhang D.M., Chen H.L., Qi M., Yin H.X. Genistein, a soybean isoflavone, reduces the production of pro-inflammatory and adhesion molecules induced by hemolysate in brain microvascular endothelial cells. Acta Neurol. Belg. 2009, 109:32-37.
43. Mahn K., Borras C., Knock G.A., Taylor P., Khan I.Y., Sugden D., Poston L., Ward J.P., Sharpe R.M., Vina J., et al. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J. 2005, 19:1755-1757.
44. Margolis D.J., Knauss J., Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002, 359:675-677.
45. Martin P., D'Souza D., Martin J., Grose R., Cooper L., Maki R., McKercher S.R. Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. Curr. Biol. 2003, 13:1122-1128.
46. McKenna N.J., O'Malley B.W. Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann. N. Y. Acad. Sci. 2001, 949:3-5.
47. Mirza R., Dipietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol. 2009.
48. Moraes A.B., Haidar M.A., Soares J.M.J., Simoes M.J., Baracat E.C., Patriarca M.T. The effects of topical isoflavones on postmenopausal skin: double-blind and randomized clinical trial of efficacy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009.
49. Most W., Schot L., Ederveen A., van der Wee-Pals L., Papapoulos S., Lowik C. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis. J. Bone Miner. Res. 1995, 10:1523-1530.
50. Nabel E.G. The Women's Health Initiative. Science 2006, 313:1703.
51. Newton K.M., LaCroix A.Z., Levy L., Li S.S., Qu P., Potter J.D., Lampe J.W. Soy protein and bone mineral density in older men and women: a randomized trial. Maturitas 2006, 55:270-277.
52. Pfitscher A., Reiter E., Jungbauer A. Receptor binding and transactivation activities of red clover isoflavones and their metabolites. J. Steroid Biochem. Mol. Biol. 2008, 112:87-94.
53. Sadowska-Krowicka H., Mannick E.E., Oliver P.D., Sandoval M., Zhang X.J., Eloby-Childess S., Clark D.A., Miller M.J. Genistein and gut inflammation: role of nitric oxide. Proc. Soc. Exp. Biol. Med. 1998, 217:351-357.
54. Seibel J., Molzberger A.F., Hertrampf T., Laudenbach-Leschowski U., Diel P. Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur. J. Nutr. 2009, 48:213-220.
55. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 1998, 68:1333S-1346S.
56. Simpson D.M., Ross R. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J. Clin. Invest. 1972, 51:2009-2023.
57. Verdrengh M., Jonsson I.M., Holmdahl R., Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm. Res. 2003, 52:341-346.
58. Widyarini S., Spinks N., Husband A.J., Reeve V.E. Isoflavonoid compounds from red clover (Trifolium pratense) protect from inflammation and immune suppression induced by UV radiation. Photochem. Photobiol. 2001, 74:465-470.
59. Williamson-Hughes P.S., Flickinger B.D., Messina M.J., Empie M.W. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006, 13:831-839.
60. Wood J.M., Bold G., Buchdunger E., Cozens R., Ferrari S., Frei J., Hofmann F., Mestan J., Mett H., O'Reilly T., et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000, 60:2178-2189.
61. Wysocki A.B., Staiano-Coico L., Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 1993, 101:64-68.
62. Yamada T., Aoyama Y., Owada M.K., Kawakatsu H., Kitajima Y. Scraped-wounding causes activation and association of C-Src tyrosine kinase with microtubules in cultured keratinocytes. Cell Struct. Funct. 2000, 25:351-359.
63. Yellayi S., Naaz A., Szewczykowski M.A., Sato T., Woods J.A., Chang J., Segre M., Allred C.D., Helferich W.G., Cooke P.S. The phytoestrogen genistein induces thymic and immune changes: a human health concern?. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:7616-7621.